Cargando…
PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer
The p38 MAP kinase is a promising cancer drug target but its therapeutic effect is not fully understood. Here we report that the response of colorectal cancer (CRC) to p38 inhibitors (p38i) is highly variable: while p38i induces regression of one subgroup of CRCs, it stimulates growth of another sub...
Autores principales: | Zhang, Yanjie, Wang, Xiaowen, Qin, Xiaoyu, Wang, Xinxin, Liu, Feng, White, Eileen, Zheng, X.F. Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703732/ https://www.ncbi.nlm.nih.gov/pubmed/26844273 http://dx.doi.org/10.1016/j.ebiom.2015.11.031 |
Ejemplares similares
-
The Human Cytomegalovirus U(L)38 protein drives mTOR-independent metabolic flux reprogramming by inhibiting TSC2
por: Rodríguez-Sánchez, Irene, et al.
Publicado: (2019) -
SLC38A10 Regulate Glutamate Homeostasis and Modulate the AKT/TSC2/mTOR Pathway in Mouse Primary Cortex Cells
por: Tripathi, Rekha, et al.
Publicado: (2022) -
The TSC-mTOR pathway regulates macrophage polarization
por: Byles, Vanessa, et al.
Publicado: (2013) -
p38γ and δ promote heart hypertrophy by targeting the mTOR-inhibitory protein DEPTOR for degradation
por: González-Terán, Bárbara, et al.
Publicado: (2016) -
Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells
por: Zhou, Ling, et al.
Publicado: (2023)